This medical technology startup develops an autonomous, hands-free ankle-brachial index (ABI) test using ultrasound for early diagnosis of peripheral artery disease (PAD). Their solution provides accurate and reimbursable diagnostic capabilities, streamlining the PAD screening process for healthcare providers.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for Ankle-Brachial Index (ABI) testing, the primary screening tool for Peripheral Artery Disease (PAD), often require specialized skills, leading to potential inaccuracies and discomfort for patients. A significant percentage of PAD patients are asymptomatic, and inaccurate test results can lead to delayed diagnosis and increased risk of severe complications, including limb loss and mortality.
Solution
CorRen Medical offers UltraSense, an autonomous, hands-free ultrasound system enhanced by AI, designed to simplify and improve the accuracy of PAD diagnosis. The system uses a multi-element probe for rapid and precise vessel location, eliminating the challenges associated with traditional Doppler probes. Stochastic resonance technology amplifies weak signals, providing reliable results even in low-flow states, while advanced AI algorithms analyze the enhanced signals to generate clear, easy-to-understand diagnostic reports. UltraSense enables primary care providers to confidently diagnose PAD early, facilitating timely intervention and improved patient outcomes.
Target Audience
The primary target audience includes primary care physicians, vascular surgeons, and other healthcare providers involved in the diagnosis and management of peripheral artery disease.
Features
- Multi-element probe for quick and accurate vessel location, regardless of patient body type
- Hands-free operation enhances patient comfort and reduces operator variability
- Stochastic resonance technology boosts weak signals, improving diagnostic reliability
- Advanced AI analysis provides quick and accurate diagnosis with minimal staff training
- Easy-to-understand reports highlight key PAD indicators
- Adherence to CMS reimbursement guidelines